CSIMarket
 


Viewray Inc.  (VRAY)
Other Ticker:  
 

Viewray's Long Term Debt to Equity

VRAY's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth




VRAY Long Term Debt to Equity (Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Equity Change 12.42 % -20.1 % -15.26 % -39.74 % 39.98 %
Y / Y Long Term Debt Change 34.63 % 27.58 % 15.49 % 5.45 % -27.67 %
Long Term Debt to Equity MRQ 0.32 0.41 0.35 0.44 0.27
Overall Ranking # 686 # 0 # 1379 # 1257 # 1049
Seq. Equity Change 22.11 % -15.42 % 26.21 % -13.75 % -13.21 %
Seq. Long Term Debt Change -5.38 % 0.14 % 0.14 % 41.87 % -10.33 %



Long Term Debt to Equity forth quarter 2021 Comment
Due to long-term debt repayement of -5.38% Viewray improved Long Term Debt to Equity in forth quarter 2021 to 0.32, below company's average Long Term Debt to Equity.

Within Medical Equipment & Supplies industry in the forth quarter 2021, 31 other companies have achieved lower Long Term Debt to Equity than Viewray. While Long Term Debt to Equity total ranking has deteriorated compare to the previous quarter from 0 to 686.

Explain Long Term Debt to Equity Ratio?
Learn more about VRAY
Long Term Debt to Equity Ratio VRAY on the trailing twelve month basis
Long Term Debt to Equity forth quarter 2021 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 32
Healthcare Sector # 95
Overall Market # 686


Long Term Debt to Equity Statistics
High Average Low
22.4 1.94 0.25
(Dec 31 2017)   (Dec 31 2019)




Financial Statements
Viewray's Equity $ 170 Millions Visit VRAY's Balance sheet
Viewray's Long Term Debt $ 54 Millions Visit VRAY's Balance sheet
Source of VRAY's Sales Visit VRAY's Sales by Geography


Cumulative Viewray's Long Term Debt to Equity

VRAY's Long Term Debt to Equity for the trailling 12 Months

VRAY Long Term Debt to Equity

(Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Equity TTM Growth 12.42 % -20.1 % -15.26 % -39.74 % 39.98 %
Y / Y Long Term Debt TTM Growth 34.63 % 27.58 % 15.49 % 5.45 % -27.67 %
Long Term Debt to Equity TTM 0.37 0.36 0.32 0.29 0.26
Total Ranking TTM # # # # #
Seq. Equity TTM Growth 22.11 % -15.42 % 26.21 % -13.75 % -13.21 %
Seq. Long Term Debt TTM Growth -5.38 % 0.14 % 0.14 % 41.87 % -10.33 %


TTM Long Term Debt to Equity Comment
On the trailing twelve months basis Despite of the long-term debt repayement of -5.38% in IV. Quarter, Long Term Debt to Equity improved to 0.37, above Viewray's average Long Term Debt to Equity.
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry VRAY recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compare to previous quarter at no. 0.

Explain Long Term Debt to Equity Ratio?
Learn more about VRAY
Long Term Debt to Equity Ratio VRAY on the trailing twelve month basis

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry #
Healthcare Sector #
Within the Market # 0


TTM Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Long Term Debt to Equity in the quarter ending Dec 31 2021, within Medical Equipment & Supplies Industry Long Term Debt to EquityDec 31 2021 MRQ Long Term DebtDec 31 2021 MRQ Equity
Haemonetics Corporation  0.87 $ 633.118  Millions$ 730.775  Millions
Apollo Endosurgery inc   0.87 $ 52.986  Millions$ 61.237  Millions
Conmed Corporation  0.86 $ 672.407  Millions$ 785.435  Millions
Stryker Corp  0.84 $ 12,472.000  Millions$ 14,877.000  Millions
Integra Lifesciences Holdings Corp  0.82 $ 1,388.683  Millions$ 1,684.804  Millions
Motus Gi Holdings Inc   0.78 $ 7.552  Millions$ 9.657  Millions
Dexcom Inc   0.76 $ 1,702.700  Millions$ 2,251.500  Millions
Infusystem Holdings Inc  0.68 $ 32.748  Millions$ 48.272  Millions
Neuropace Inc   0.68 $ 49.847  Millions$ 73.503  Millions
Becton Dickinson And Company  0.68 $ 16,360.000  Millions$ 24,160.000  Millions
Tandem Diabetes Care Inc   0.65 $ 281.467  Millions$ 433.112  Millions
Cerus Corporation  0.65 $ 54.724  Millions$ 84.619  Millions
Bioventus Inc   0.64 $ 339.644  Millions$ 533.789  Millions
National Vision Holdings Inc   0.61 $ 566.081  Millions$ 925.980  Millions
Qhslab Inc  0.61 $ 0.503  Millions$ 0.824  Millions
Vapotherm Inc   0.60 $ 39.726  Millions$ 66.667  Millions
Silk Road Medical Inc   0.57 $ 44.786  Millions$ 79.240  Millions
Biolase Inc   0.54 $ 13.603  Millions$ 25.208  Millions
Boston Scientific Corporation  0.53 $ 8,804.000  Millions$ 16,622.000  Millions
Transmedics Group Inc   0.52 $ 35.197  Millions$ 67.854  Millions
Tessco Technologies Incorporated  0.50 $ 38.272  Millions$ 76.742  Millions
Nevro Corp   0.50 $ 151.310  Millions$ 303.616  Millions
Pro Dex Inc  0.50 $ 10.899  Millions$ 22.005  Millions
Glaukos Corp  0.48 $ 280.026  Millions$ 587.151  Millions
Patterson Companies Inc   0.47 $ 488.353  Millions$ 1,044.178  Millions
Teleflex Incorporated  0.46 $ 1,740.102  Millions$ 3,754.748  Millions
Plus Therapeutics Inc   0.46 $ 5.005  Millions$ 10.836  Millions
Medtronic Plc  0.46 $ 24,290.000  Millions$ 52,713.000  Millions
Assure Holdings Corp   0.45 $ 13.169  Millions$ 28.956  Millions
The Pennant Group Inc   0.45 $ 51.372  Millions$ 114.244  Millions

Date modified: 2022-08-04T16:59:14+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UNF's Profile

Stock Price

UNF's Financials

Business Description

Fundamentals

Charts & Quotes

UNF's News

Suppliers

UNF's Competitors

Customers & Markets

Economic Indicators

UNF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071